Zobrazeno 1 - 10 of 83 pro vyhledávání: '"Hans Peter Stoll"'
1
Akademický článek
First clinical evidence characterizing safety and efficacy of the new CoCr Biolimus-A9 eluting stent: The Biomatrix Alpha™ registry
Autor: Ian B.A. Menown, Mamas A. Mamas, James M. Cotton, David Hildick-Smith, Franz R. Eberli, Gregor Leibundgut, Damras Tresukosol, Carlos Macaya, Samuel Copt, Sara Sadozai Slama, Hans-Peter Stoll
Publikováno v: International Journal of Cardiology: Heart & Vasculature, Vol 26, Iss , Pp - (2020)
Background: The biolimus-eluting stent (BES) was the first to elute anti-proliferative drug from a biodegradable polymer. In the randomized LEADERS trial, a stainless steel BES showed non-inferior efficacy compared to a sirolimus-eluting stent and a
Externí odkaz: https://doaj.org/article/0b54c11e43934e80814b6554ea0f35ab
Zobrazit plný text záznamu
2
Polymer ‐free Biolimus‐A9 coated thin strut stents for patients at high bleeding risk 1‐year results from the LEADERS FREE III study
Autor: Philippe Brunel, Marie-Claude Morice, Philippe Garot, Janus Lipiecki, Jacques Berland, Stéphane Cook, Hans-Peter Stoll, Philip Urban, Luc Maillard, Didier Carrié, Thomas Hovasse, Sara Sadozai Slama, Diana Schütte, Franz R. Eberli
Publikováno v: Catheterization and Cardiovascular Interventions. 99:593-600
BACKGROUND In patients at high bleeding risk (HBR), the LEADERS FREE (LF) trial established the safety and efficacy of a polymer-free drug coated (Biolimus-A9) stainless steel stent (SS-DCS) with 30 days of dual antiplatelet treatment (DAPT). In LEAD
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ddecd7eec44630820f878b5d5e81868f
https://doi.org/10.1002/ccd.29869
Zobrazit plný text záznamu
3
Drug-coated stents versus bare metal stents in Academic Research Consortium-defined high bleeding risk patients
Autor: Stuart J. Pocock, Sunil V. Rao, Hans-Peter Stoll, Davide Capodanno, Philip Urban, Samuel Copt, Martin B. Leon, Mitchell W. Krucoff, Roxana Mehran, Sara Sadozai Slama, Guillaume Marquis-Gravel, Jean-François Tanguay, Marie-Claude Morice
Publikováno v: EuroIntervention
BACKGROUND: More effective and progressively safer generations of drug-elut-ing stents (DES) have replaced bare metal stents (BMS) in rou-tine clinical practice. However, patients considered to be at high bleeding risk (HBR) have traditionally been u
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::498f870bf113f371abe5a014321f0ceb
https://doi.org/10.4244/eij-d-20-00749
Zobrazit plný text záznamu
4
Polymer-free drug-coated vs. bare-metal coronary stents in patients undergoing non-cardiac surgery: a subgroup analysis of the LEADERS FREE trial
Autor: Florian Krackhardt, Hans-Peter Stoll, Ralph Toelg, Philip Urban, Gert Richardt, Abdelhakim Allali, Rune Wiseth, Samuel Copt, Marie-Claude Morice, Mohamed Abdellaoui, Mohammad Abdelghani
Publikováno v: Clinical research in cardiology, 110(2), 162-171. D. Steinkopff-Verlag
Aims: To compare the outcomes of patients undergoing non-cardiac surgery (NCS) after PCI with either a drug-coated stent (DCS) or a bare-metal stent (BMS), followed by 1-month dual antiplatelet therapy and to explore the impact of the timing of NCS.
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::edd75422bd354f22a03da302b6bff6a5
https://doi.org/10.1007/s00392-020-01672-3
Zobrazit plný text záznamu
5
Clinical relevance of ticagrelor monotherapy following 1-month dual antiplatelet therapy after bifurcation percutaneous coronary intervention: Insight from GLOBAL LEADERS trial
Autor: Luc Janssens, Hans Peter Stoll, Pascal Vranckx, Marco Valgimigli, Antonio Colombo, Hidenori Komiyama, Peter Jüni, Ply Chichareon, Stephan Windecker, Philippe Gabriel Steg, Chun Chin Chang, Kenneth De Wilder, Norihiro Kogame, Yves Louvard, Alaide Chieffo, Mariusz Tomaniak, Yoshinobu Onuma, Scot Garg, Kuniaki Takahashi, Christian W. Hamm, Rodrigo Modolo, Patrick W. Serruys
Publikováno v: Catheterization and cardiovascular interventions, 96(1), 100-111. Wiley-Liss Inc.
Catheterization and Cardiovascular Interventions, 96(1), 100-111. Wiley-Liss Inc.
Background The aim of this study was to investigate the impact of ticagrelor monotherapy following 1-month dual antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI) for bifurcation lesions. Methods GLOBAL LEADERS was a randomize
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a48a444112a1029935ed4fadbc7d5368
http://www.scopus.com/inward/record.url?scp=85071149070&partnerID=8YFLogxK
Zobrazit plný text záznamu
6
Impacto del acceso vascular en el pronóstico tras la angioplastia coronaria en pacientes con alto riesgo hemorrágico: subanálisis predefinido del estudio LEADERS FREE
Autor: Victor Alfonso Jimenez Diaz, Alex Abizaid, Alberto Ortiz Saez, Philippe Brunel, Guillermo Bastos Fernández, Samuel Copt, Andrés Iñiguez, Jonathan Byrne, Hans-Peter Stoll, Philip Urban, Maurizio Tespilli, Darren Walters, Thomas Hovasse, Marie-Claude Morice
Publikováno v: Revista Española de Cardiología. 73:536-545
Resumen Introduccion y objetivos El objetivo es evaluar el impacto del acceso vascular en las complicaciones hemorragicas tras una intervencion coronaria percutanea en pacientes con alto riesgo de sangrado (ARS) a los 30 dias y a los 2 anos. Metodos
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::95f19ed83a50eb91b10e8115e4c9f982
https://doi.org/10.1016/j.recesp.2019.07.019
Zobrazit plný text záznamu
7
Efficacy and Safety of Ticagrelor Monotherapy in Patients Undergoing Multivessel PCI
Autor: Scot Garg, Rodrigo Modolo, Patrick W. Serruys, Robbert J. de Winter, Robert Zweiker, Mariusz Tomaniak, Michael Magro, Norihiro Kogame, Jan G.P. Tijssen, Marco Valgimigli, Christian W. Hamm, Kuniaki Takahashi, Philippe Gabriel Steg, Saqib Chowdhary, Pascal Vranckx, Hans-Peter Stoll, Didier Carrié, Paul Jau Lueng Ong, Ingo Eitel, Ply Chichareon, Joanna J. Wykrzykowska, Chun Chin Chang, Michael Mundt Ottesen, Yoshinobu Onuma, Stephan Windecker
Publikováno v: Journal of the American College of Cardiology, 74(16), 2015-2027. Elsevier Inc.
Journal of the American College of Cardiology, 74(16), 2015-2027. Elsevier USA
Background: Data on optimal antiplatelet treatment regimens in patients who undergo multivessel percutaneous coronary intervention (PCI) are sparse. Objectives: This post hoc study investigated the impact of an experimental strategy (1-month dual ant
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ca48d84c95a19334c6c3d27d85dc9fd7
https://hdl.handle.net/1765/120127
Zobrazit plný text záznamu
8
Thin- versus thick-strut polymer-free biolimus-eluting stents:The BioFreedom QCA randomised trial
Autor: Lisette Okkels Jensen, Bruno García Del Blanco, Carlos Macaya, Raul Moreno, Jens Flensted Lassen, Angel Cequier, Diana Schütte, Ricardo Costa, Pedro Perez-Fuentes, Armando Pérez de Prado, Hans-Peter Stoll, Hans-Henrik Tilsted, Manel Sabaté
Publikováno v: Sabaté, M, Okkels-Jensen, L, Tilsted, H H, Moreno, R, Del Blanco, B G, MacAya, C, De Prado, A P, Cequier, A, Pérez-Fuentes, P, Schütte, D, Costa, R, Stoll, H P & Lassen, J F 2021, ' Thin-versus thick-strut polymer-free biolimus-eluting stents : The BioFreedom QCA randomised trial ', EuroIntervention, vol. 17, no. 3, pp. 233-239 . https://doi.org/10.4244/EIJ-D-20-01162
EuroIntervention
Background: The BioFreedom drug-coated stent with a stainless steel platform (BF-SS) has been demonstrated to be efficacious in patients at high bleeding risk and receiving only one-month dual antiplatelet therapy. Aims: The aim of this study was to
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d7216a13b005e4faf24555de02607dcf
https://portal.findresearcher.sdu.dk/da/publications/df51ac0f-2597-463d-ae50-93be0e10e28f
Zobrazit plný text záznamu
9
Sex-Based Outcomes in Patients With a High Bleeding Risk After Percutaneous Coronary Intervention and 1-Month Dual Antiplatelet Therapy: A Secondary Analysis of the LEADERS FREE Randomized Clinical Trial
Autor: Samuel Copt, Christian Spaulding, Hans-Peter Stoll, Roxana Mehran, Marie-Claude Morice, Jaya Chandrasekhar, Philip Urban, Irene M. Lang, Ute Windhoevel
Publikováno v: JAMA Cardiol
IMPORTANCE: Female sex has been identified as a risk factor for bleeding after percutaneous coronary intervention (PCI) and may have contributed to the underuse of drug-eluting stents in women. This risk may be further enhanced among patients with a
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2643d6d4dd0f63dcdb529b3b74224a65
https://pubmed.ncbi.nlm.nih.gov/33377943
Zobrazit plný text záznamu
10
Global Approach to High Bleeding Risk Patients With Polymer-Free Drug-Coated Coronary Stents: The LF II Study
Autor: Stuart J. Pocock, Mitchell W. Krucoff, Mohamed Abdel-Wahab, Corie Diaz, Jean-François Tanguay, Yiran Zhang, Marie-Claude Morice, Brent T. McLaurin, Shamir R. Mehta, Benjamin Faurie, Thomas McAndrew, David J. Cohen, Philip Urban, Sunil V. Rao, Martin B. Leon, Hans-Peter Stoll, Matthew J. Price
Publikováno v: Circulation. Cardiovascular interventions. 13(4)
Background: High bleeding risk (HBR) patients undergoing percutaneous coronary intervention have been widely excluded from randomized device registration trials. The LF study (LEADERS FREE) reported superior outcomes of HBR patients receiving 30-day
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::475e809a6e6b67d5e8d7244cc63284e0
https://pubmed.ncbi.nlm.nih.gov/32279569
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje